Core Insights - The report highlights that as of July 29, 2024, there are 5,817 listed companies in the A-share market, with a total of 1,144 secretaries earning over 1 million yuan, accounting for over 21% of the total [1] - The total salary for secretaries in the A-share market reached 4.086 billion yuan, with an average salary of 754,300 yuan [1] Group 1: Salary Overview - In the computer equipment industry, there are 103 listed companies, with an average secretary salary of 690,500 yuan, ranking 73rd among 125 secondary industries [1] - The average salary for secretaries in the computer equipment industry decreased by 32,900 yuan compared to the previous year, ranking 102nd in salary growth among 125 primary industries [1] - Among the 103 secretaries, 45 have salaries between 500,000 and 1 million yuan, representing over 40%, while only 18 earn over 1 million yuan, accounting for less than 20% [1] Group 2: Individual Salary Highlights - The highest-paid secretary in the computer equipment industry is Xu Yanyan from Langchao Information, with a salary of 3.206 million yuan, significantly higher than others [1] - The second highest is Huang Fanghong from Hikvision, earning 2.2975 million yuan [1] - The lowest-paid secretary among those in office for the entire year is Wang Dongxue from China Shipbuilding, with a salary of 238,100 yuan [1] Group 3: Age and Education Insights - The age distribution of secretaries ranges from 32 to 59 years, with the median age between 41 and 47 years, where 50 individuals fall into this age range, nearly half of the total [2] - The highest average salary is found in the 50-year age group, at 1.473 million yuan, primarily driven by Wu Jian from Dahua Technology, who earns 2.192 million yuan [2] - Among the 103 secretaries, 50 hold master's degrees and 50 hold bachelor's degrees, together accounting for over 90% of the total [2] Group 4: Salary and Stock Performance Relationship - An analysis of secretary salaries in three segments (0-1.5 million yuan) shows a positive correlation between salary increases and stock price performance, with corresponding annual stock price changes of 2.02%, 1.81%, and 25.53% [3] - This suggests that higher secretary salaries may be linked to improved stock performance, indicating the effectiveness of the secretary system in the computer equipment industry [3]

证券代码：300884 证券简称：狄耐克 公告编号：2025-030 厦门狄耐克智能科技股份有限公司 关于高级管理人员股份减持计划实施完成的公告 公司高级管理人员黄发扬先生保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 厦门狄耐克智能科技股份有限公司（以下简称"公司"）于 2025 年 7 月 2 日在巨潮资讯网（http://www.cninfo.com.cn）上披露了《关于公司高级管理人员 减持股份的预披露公告》（公告编号：2025-029）。公司高级管理人员黄发扬先 生持有公司股份 120,000 股，占公司总股本的 0.0473%，占剔除公司回购专用证 券账户持股数量后总股本的 0.0482%，计划自上述公告披露之日起 15 个交易日 后的 3 个月内（窗口期除外）通过集中竞价交易方式减持公司股份不超过 30,000 股，占公司总股本的比例不超过 0.0118%，占剔除公司回购专用证券账户持股数 量后总股本的比例不超过 0.0121%。 近日，公司收到高级管理人员黄发扬先生出具的《关于股份减持计划实 ...

狄耐克最新一期业绩显示，截至2025一季报，公司营业总收入1.14亿元、同比减少9.24%，归属净利润 271.07万元，同比减少351.68%，扣非净利润684.36万元，同比减少14.13%，流动比率2.709、速动比率 2.355、资产负债率25.41%。 金融界消息 截至2025年8月5日收盘，狄耐克（300884）报收于14.03元，上涨2.93%，换手率10.72%， 成交量20.53万手，成交金额2.84亿元。 天眼查商业履历信息显示，厦门狄耐克智能科技股份有限公司，成立于2005年，位于厦门市，是一家以 从事计算机、通信和其他电子设备制造业为主的企业。企业注册资本25386.282万人民币，实缴资本 9000万人民币。公司法定代表人为缪国栋。 资金流向方面，今日主力资金净流入1372.76万元，占比成交额4.83%。其中，超大单净流入2010.12万 元、占成交额7.08%，大单净流出637.37万元、占成交额2.24%，中单净流出流出635.01万元、占成交额 2.24%，小单净流出737.74万元、占成交额2.6%。 来源：金融界 通过天眼查大数据分析，厦门狄耐克智能科技股份有限公司共对外 ...

金融界消息 截至2025年7月30日收盘，狄耐克（300884）报收于13.34元，下跌1.4%，换手率4.35%，成 交量8.32万手，成交金额1.11亿元。 来源：金融界 狄耐克最新一期业绩显示，截至2025一季报，公司营业总收入1.14亿元、同比减少9.24%，归属净利润 271.07万元，同比减少351.68%，扣非净利润684.36万元，同比减少14.13%，流动比率2.709、速动比率 2.355、资产负债率25.41%。 资金流向方面，今日主力资金净流出1029.13万元，占比成交额9.27%。其中，超大单净流出238.27万 元、占成交额2.15%，大单净流出790.86万元、占成交额7.12%，中单净流出流出724.42万元、占成交额 6.52%，小单净流入1753.55万元、占成交额15.79%。 通过天眼查大数据分析，厦门狄耐克智能科技股份有限公司共对外投资了17家企业，参与招投标项目 251次，知识产权方面有商标信息230条，专利信息500条，此外企业还拥有行政许可27个。 天眼查商业履历信息显示，厦门狄耐克智能科技股份有限公司，成立于2005年，位于厦门市，是一家以 从事计算机、通信 ...

Group 1 - The Beijing Future Science City Management Committee has developed a draft implementation plan for the "Artificial Intelligence + Pharmaceutical Health" industry in Changping District, focusing on brain-computer interface (BCI) innovation [1] - The plan emphasizes the development and application of BCI products, supporting research in key areas such as neural signal acquisition, decoding, control, and feedback [1] - The document encourages medical and health institutions in the region to adopt BCI products for clinical applications in treating neurological and mental disorders, as well as in smart rehabilitation and health monitoring [1] Group 2 - Open Source Securities highlights the significant potential of the downstream application market for brain-computer interfaces, which connect the brain with external devices for information exchange [2] - The BCI technology is expected to accelerate its implementation due to favorable policies and technological advancements, benefiting companies such as Rock Mountain Technology, Zhongke Information, and others [2] - The applications of BCI span across medical fields for disease warning, diagnosis, treatment, and functional enhancement, as well as in consumer and industrial sectors [2]

Industry Insights - Shanghai YanSi Brain-like AI Research Institute collaborates with Huashan Hospital to achieve breakthroughs in brain-computer interface technology, enabling real-time display of intended Chinese phrases from patients with implanted electrodes [1] - Brain-computer interfaces are recognized as a frontier technology with vast applications in healthcare, wellness, and education, with 2025 anticipated as a pivotal year for the industry [1] - The global market for brain-computer interfaces is projected to grow by approximately $10 billion over the next decade, with China's market rapidly catching up, potentially exceeding a trillion yuan in comprehensive industry scale [1] Company Developments - Dineike focuses on the brainwave interaction sector, particularly in sleep health, cognitive rehabilitation, and concentration enhancement, with initial production of smart sleep devices and brainwave monitoring instruments underway [2] - Innovation Medical has stakes in Boling Brain Machine, a tech company centered on brain-computer interface technology and high-end medical devices, and in Quan Diagnostic, which specializes in AI medical product development and sales [2]

Group 1 - The first Brain-Machine Intelligence and Mental Health Innovation Development and Application Forum was held on July 11, 2025, focusing on the theme "Brain-Machine Intelligence Empowering Mental Health" [1] - The forum was co-hosted by Fujian Artificial Intelligence Society, Xiamen University School of Information, and Xiamen Dineike Intelligent Technology Co., Ltd. [1] - Brain-machine interaction is expected to revolutionize various fields such as sleep health, cognitive rehabilitation, and human-machine collaboration, with significant impacts on smart living [1] Group 2 - Dineike has been focusing on the smart technology sector for 20 years and is actively developing core technologies in brainwave interaction, particularly in sleep health and cognitive rehabilitation [1] - The chairman of Dineike, Miao Guodong, emphasized the company's strategy to meet strict standards in the medical health sector while also addressing the broad demands of the civilian market [2] - Dineike aims to accelerate the transition of cutting-edge technology from the laboratory to large-scale applications and to transform research results into products [2]

Group 1 - The first "Brain-Machine Intelligence and Brain Health Innovation Development and Application Forum" successfully concluded, marking a new stage of deep integration between industry, academia, and medicine in the field of brain-machine interface technology [1] - The forum highlighted the significance of brain-machine interfaces as a core area for cultivating new economic momentum and enhancing international competitiveness, supported by national strategic initiatives [2] - Experts discussed breakthroughs in brain-machine interface technology, emphasizing its applications in medical rehabilitation and cognitive enhancement, which are expected to lead to significant advancements in human cognition [2][3] Group 2 - The company Dineike announced its strategic focus on brainwave interaction technology, targeting three key areas: sleep health, focus enhancement, and cognitive rehabilitation, with plans to implement a closed-loop system for monitoring and intervention [3] - Dineike's chairman emphasized the company's capabilities in research and development, multi-scenario adaptation, and advanced manufacturing systems, which will facilitate the expansion and commercialization of brainwave interaction technology [3][4] - The national emphasis on brain-machine interaction technology provides a broad development space for technology companies like Dineike, which aims to foster an open and collaborative industrial ecosystem while creating social value [4]

Investment Rating - The investment rating for the computer industry is optimistic (maintained) [1] Core Insights - The brain-computer interface (BCI) market has significant potential, with global medical applications expected to reach $40 billion by 2030 and $145 billion by 2040 [5][36] - The technology is maturing, with companies like Neuralink receiving FDA approval for human trials, indicating a shift from concept to practical application [6][8] - Policy support is increasing, with various regions in China implementing plans to accelerate the commercialization of BCI technologies [7][45] Summary by Sections 1. Brain-Computer Interface: Continuous Breakthrough - BCI creates a communication channel between the brain and external devices, enabling direct information exchange [17] - The global BCI market was valued at $2.35 billion in 2023, with a projected CAGR of 16.55% from 2023 to 2033 [35] 2. Policy and Technology Resonance: Bright Commercial Prospects for BCI 2.1 Policy: BCI Medical Pricing Implementation Accelerates Commercialization - Major countries are investing in BCI research, with the U.S. and EU leading in funding and project initiatives [41][44] - China's government has issued multiple directives to guide BCI development, including the establishment of independent pricing for BCI services [45][46] 2.2 Technology: Positive Progress in Clinical Trials, Approaching Industrialization - The BCI system faces numerous technical barriers, particularly in balancing performance and commercial viability [48] - China's BCI sector is rapidly advancing, with increasing publications and patents in the field [51][52] 3. Beneficiary Companies 3.1 Neuralink: Pioneer in Invasive BCI Technology - Neuralink is leading in invasive BCI technology, having initiated human trials and planning further patient implants [55][66] 3.2 Strong Brain Technology: Leader in Non-Invasive BCI - Strong Brain Technology focuses on non-invasive BCI solutions, having developed multiple products and secured significant funding [67][69] 3.3 Rock Mountain Technology: Forward-Looking Layout of Brainwave Large Models - Rock Mountain Technology is developing brainwave large models to enhance human-computer interaction systems [80]

证券代码：300884 证券简称：狄耐克 公告编号：2025-029 厦门狄耐克智能科技股份有限公司 公司于近日收到高级管理人员黄发扬先生出具的《股份减持计划告知函》， 现将相关情况公告如下： 一、股东的基本情况 | 股东名称 | 职务 | 持有公司股 | 占公司总股本 | 占剔除回购专用证券账户 | | --- | --- | --- | --- | --- | | | | 份数量（股） | 比例 | 持股数量后总股本比例 | | 黄发扬 | 副总经理 | 120,000 | 0.0473% | 0.0482% | 二、本次减持计划的主要内容 （一）减持计划 关于公司高级管理人员减持股份的预披露公告 公司高级管理人员黄发扬先生保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 厦门狄耐克智能科技股份有限公司（以下简称"公司"或"本公司"）高级 管理人员黄发扬先生持有公司股份 120,000 股，占公司总股本的 0.0473%，占剔 除公司回购专用证券账户持股数量后总股本的 0.0482%，计划自本 ...